Galecto GLTO Stock
$28.69
0.000000%
Add to favorites
SECTOR
INDUSTRY
COUNTRY
Exchange
Market Cap
$1.73B
LOW - HIGH [24H]
$0.00
-
$0.00
VOLUME [24H]
$0.00
P/E Ratio
0
Earnings per share
$0.00
ISIN
US36322Q2066
Galecto Price Chart
Galecto GLTO Financial and Trading Overview
| Galecto stock price | 28.69 USD |
| Previous Close | 28.91 USD |
| Open | 28.75 USD |
| Bid | 27.92 USD x 100 |
| Ask | 29.15 USD x 100 |
| Day's Range | 26.43 - 30.09 USD |
| 52 Week Range | 2.01 - 38.33 USD |
| Volume | 231.44K USD |
| Avg. Volume | 161.02K USD |
| Market Cap | 1.73B USD |
| Beta (5Y Monthly) | 1.572 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | 0 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 46.75 USD |
GLTO Valuation Measures
| Enterprise Value | 27.66M USD |
| Trailing P/E | N/A |
| Forward P/E | -30.20477 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 5.7117267 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | -2.332 |
Trading Information
Galecto Stock Price History
| Beta (5Y Monthly) | 1.572 |
| 52-Week Change | 482.28% |
| S&P500 52-Week Change | 26.60% |
| 52 Week High | 38.33 USD |
| 52 Week Low | 2.01 USD |
| 50-Day Moving Average | 26.48 USD |
| 200-Day Moving Average | 14.12 USD |
GLTO Share Statistics
| Avg. Volume (3 month) | 161.02K USD |
| Avg. Daily Volume (10-Days) | 199.37K USD |
| Shares Outstanding | 60.24M |
| Float | 1.05M |
| Short Ratio | 1.26 |
| % Held by Insiders | 1.46% |
| % Held by Institutions | 7.96% |
| Shares Short | 277K |
| Short % of Float | 0.45% |
| Short % of Shares Outstanding | 0.45% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:25 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2024 |
| Most Recent Quarter (mrq) | September 30, 2025 |
| Next Fiscal Year End | December 31, 2025 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -43.54% |
| Return on Equity (ttm) | -109.48% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | -11862000 USD |
| Net Income Avi to Common (ttm) | -15844000 USD |
| Diluted EPS (ttm) | -12.11 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 7.61M USD |
| Total Cash Per Share (mrq) | 5.73 USD |
| Total Debt (mrq) | 72K USD |
| Total Debt/Equity (mrq) | 0.9 USD |
| Current Ratio (mrq) | 3.731 |
| Book Value Per Share (mrq) | 5.023 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -12228000 USD |
| Levered Free Cash Flow (ttm) | -7066875 USD |
Profile of Galecto
| Country | United States |
| State | N/A |
| City | Copenhagen |
| Address | Ole Maaloes Vej 3 |
| ZIP | 2200 |
| Phone | 45 70 70 52 10 |
| Website | https://galecto.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 5 |
Damora Therapeutics, Inc., a clinical-stage biotechnology company, develops molecule therapeutics for the treatment of fibrosis, cancer, inflammation, and other related diseases. It develops GB3226, a preclinical small molecule dual inhibitor of ENL-YEATS and FLT3 and GB1211, an oral small molecule inhibitor of galectin-3 to treat multiple types of oncology and liver disease indications. The company was founded in 2011 and is headquartered in Copenhagen, Denmark.
Q&A For Galecto Stock
What is a current GLTO stock price?
Galecto GLTO stock price today per share is 28.69 USD.
How to purchase Galecto stock?
You can buy GLTO shares on the Tech Market Small exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Galecto?
The stock symbol or ticker of Galecto is GLTO.
Which industry does the Galecto company belong to?
The Galecto industry is Biotechnology.
How many shares does Galecto have in circulation?
The max supply of Galecto shares is 60.24M.
What is Galecto Price to Earnings Ratio (PE Ratio)?
Galecto PE Ratio is 0.00000000 now.
What was Galecto earnings per share over the trailing 12 months (TTM)?
Galecto EPS is 0 USD over the trailing 12 months.
Which sector does the Galecto company belong to?
The Galecto sector is Healthcare.
Galecto GLTO included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| US Tech Composite IXIC | 26853.98 USD — |
-0.89
|
8.32B USD — | 26769.16 USD — | 27130.88 USD — | — - | 8.32B USD — |
| US Tech Global Select Market Com NQGS | 13180.97 USD — |
-0.87
|
— — | 13139.79 USD — | 13316.81 USD — | — - | — — |
| US Tech Health Care IXHC | 1133.51 USD — |
+1.54
|
— — | 1113.35 USD — | 1133.95 USD — | — - | — — |
- {{ link.label }} {{link}}